Abstract
In this randomized controlled study (RCT) we compare the clinical efficacy of the Orsiro Hybrid Drug Eluting Stent (Orsiro) with the Xience Prime™ Everolimus Eluting Stent (Xience) at 2 years in the complete study population as well as in the diabetic and small vessel subgroups, which are known to
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
